Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.

Hunt KJ, Jenkins AJ, Fu D, Stevens D, Ma JX, Klein RL, Azar M, Zhang SX, Lopes-Virella MF, Lyons TJ; VADT Investigators.

J Diabetes Complications. 2019 Oct;33(10):107410. doi: 10.1016/j.jdiacomp.2019.107410. Epub 2019 Jul 26.

PMID:
31434620
2.

Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).

Agrawal L, Azad N, Bahn GD, Ge L, Reaven PD, Hayward RA, Reda DJ, Emanuele NV; VADT Study Group.

Diabetologia. 2018 Feb;61(2):295-299. doi: 10.1007/s00125-017-4473-2. Epub 2017 Nov 3.

3.

Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.

Jenkins AJ, Fu D, Azar M, Stoner JA, Kaufman DG, Zhang S, Klein RL, Lopes-Virella MF, Ma JX, Lyons TJ; VADT investigators.

J Diabetes Complications. 2014 May-Jun;28(3):353-9. doi: 10.1016/j.jdiacomp.2014.01.008. Epub 2014 Jan 17.

4.

Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes.

Hui E, Yeung CY, Lee PC, Woo YC, Fong CH, Chow WS, Xu A, Lam KS.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2169-77. doi: 10.1210/jc.2014-2235. Epub 2014 Aug 28.

5.

Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.

Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C.

Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Review.

6.

Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis.

Terawaki H, Yamagishi S, Funakoshi Y, Matsuyama Y, Terada T, Nakayama K, Ogura M, Hosoya T, Ito S, Era S, Nakayama M.

Ther Apher Dial. 2013 Dec;17(6):625-30. doi: 10.1111/1744-9987.12020. Epub 2013 Mar 11.

PMID:
24330558
7.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D.

JAMA. 2011 Apr 20;305(15):1545-52. doi: 10.1001/jama.2011.468. Epub 2011 Apr 11.

8.

CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race.

Hui X, Matsushita K, Sang Y, Ballew SH, Fülöp T, Coresh J.

Am J Kidney Dis. 2013 Oct;62(4):691-702. doi: 10.1053/j.ajkd.2013.04.010. Epub 2013 Jun 13.

9.

Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.

Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, Rahman M; CRIC Investigators.

Am J Kidney Dis. 2013 Oct;62(4):670-8. doi: 10.1053/j.ajkd.2013.01.017. Epub 2013 Mar 13.

10.

Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Weiner DE, Park M, Tighiouart H, Joseph AA, Carpenter MA, Goyal N, House AA, Hsu CY, Ix JH, Jacques PF, Kew CE, Kim SJ, Kusek JW, Pesavento TE, Pfeffer MA, Smith SR, Weir MR, Levey AS, Bostom AG.

Am J Kidney Dis. 2019 Jan;73(1):51-61. doi: 10.1053/j.ajkd.2018.05.015. Epub 2018 Jul 20.

PMID:
30037726
11.

Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).

Anderson RJ, Bahn GD, Emanuele NV, Marks JB, Duckworth WC; VADT Study Group.

Diabetes Care. 2014 Oct;37(10):2782-8. doi: 10.2337/dc14-0284. Epub 2014 Jul 21.

12.
13.

Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.

Fung E, Chang TI, Chertow GM, Thomas IC, Asch SM, Kurella Tamura M.

Am J Kidney Dis. 2017 Nov;70(5):705-714. doi: 10.1053/j.ajkd.2017.06.025. Epub 2017 Aug 12.

14.

The kidney and cardiovascular outcome trials.

Bloomgarden Z.

J Diabetes. 2018 Feb;10(2):88-89. doi: 10.1111/1753-0407.12616.

PMID:
29031006
15.

Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.

Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.

Nephrol Dial Transplant. 2008 Dec;23(12):3851-8. doi: 10.1093/ndt/gfn356. Epub 2008 Jul 18.

PMID:
18641082
16.

Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.

Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL, Chung JS, O'Neal DN, Januszewski AS, Croft KD, Mori TA, Dragicevic G, Harper CA, Best JD, Lyons TJ, Ma JX.

Diabet Med. 2007 Dec;24(12):1345-51. Epub 2007 Oct 29.

PMID:
17971181
17.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
18.

Observation on renal outcomes in the Veterans Affairs Diabetes Trial.

Agrawal L, Azad N, Emanuele NV, Bahn GD, Kaufman DG, Moritz TE, Duckworth WC, Abraira C; Veterans Affairs Diabetes Trial (VADT) Study Group.

Diabetes Care. 2011 Sep;34(9):2090-4. doi: 10.2337/dc11-0175. Epub 2011 Jul 20.

19.

Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort.

Hunt KJ, Jaffa MA, Garrett SM, Luttrell DK, Lipson KE, Lopes-Virella MF, Luttrell LM, Jaffa AA; VADT Investigators.

Diabetes Care. 2018 Apr;41(4):840-846. doi: 10.2337/dc17-2083. Epub 2018 Jan 30.

20.

Reduced Kidney Function, Albuminuria, and Risks for All-cause and Cardiovascular Mortality in China: A Population-based Cohort Study.

Wang J, Wang F, Liu S, Zhou M, Zhang L, Zhao M.

BMC Nephrol. 2017 Jun 7;18(1):188. doi: 10.1186/s12882-017-0603-9.

Supplemental Content

Support Center